SK286852B6 - 16,17-Karbocyklické kondenzované steroidné zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

16,17-Karbocyklické kondenzované steroidné zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK286852B6
SK286852B6 SK1707-2002A SK17072002A SK286852B6 SK 286852 B6 SK286852 B6 SK 286852B6 SK 17072002 A SK17072002 A SK 17072002A SK 286852 B6 SK286852 B6 SK 286852B6
Authority
SK
Slovakia
Prior art keywords
alkyl
compound
compounds
alkenyl
steroid
Prior art date
Application number
SK1707-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK17072002A3 (sk
Inventor
Hubert Jan Jozef Loozen
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of SK17072002A3 publication Critical patent/SK17072002A3/sk
Publication of SK286852B6 publication Critical patent/SK286852B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1707-2002A 2000-06-06 2001-05-01 16,17-Karbocyklické kondenzované steroidné zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie SK286852B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201986 2000-06-06
PCT/EP2001/004868 WO2002000682A1 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Publications (2)

Publication Number Publication Date
SK17072002A3 SK17072002A3 (sk) 2003-06-03
SK286852B6 true SK286852B6 (sk) 2009-06-05

Family

ID=8171601

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1707-2002A SK286852B6 (sk) 2000-06-06 2001-05-01 16,17-Karbocyklické kondenzované steroidné zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (27)

Country Link
US (3) US7868193B2 (no)
EP (1) EP1294739B1 (no)
JP (1) JP5095902B2 (no)
KR (1) KR100769865B1 (no)
CN (1) CN1235908C (no)
AR (1) AR028080A1 (no)
AT (1) ATE293124T1 (no)
AU (2) AU5838601A (no)
BR (1) BR0111445A (no)
CA (1) CA2410220C (no)
CZ (1) CZ20024014A3 (no)
DE (1) DE60110069T2 (no)
DK (1) DK1294739T3 (no)
ES (1) ES2240454T3 (no)
HK (1) HK1052012A1 (no)
HU (1) HUP0301190A3 (no)
IL (1) IL152957A0 (no)
MX (1) MXPA02012117A (no)
NO (1) NO324247B1 (no)
PE (1) PE20020214A1 (no)
PL (1) PL203732B1 (no)
PT (1) PT1294739E (no)
RU (1) RU2255090C2 (no)
SK (1) SK286852B6 (no)
TW (1) TWI225068B (no)
WO (1) WO2002000682A1 (no)
ZA (1) ZA200209452B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194821A (en) * 1963-12-30 1965-07-13 Abbott Lab 17alpha-substituted 17beta-hydroxyestrenes
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity

Also Published As

Publication number Publication date
US7868193B2 (en) 2011-01-11
EP1294739A1 (en) 2003-03-26
JP2004501931A (ja) 2004-01-22
PE20020214A1 (es) 2002-03-13
US20040102426A1 (en) 2004-05-27
NO20025793L (no) 2002-12-02
DE60110069T2 (de) 2005-09-22
KR100769865B1 (ko) 2007-10-25
AU2001258386B2 (en) 2005-08-18
HUP0301190A3 (en) 2010-03-29
NO324247B1 (no) 2007-09-17
SK17072002A3 (sk) 2003-06-03
AU5838601A (en) 2002-01-08
RU2255090C2 (ru) 2005-06-27
CA2410220A1 (en) 2002-01-03
NO20025793D0 (no) 2002-12-02
DE60110069D1 (de) 2005-05-19
CN1433426A (zh) 2003-07-30
HUP0301190A2 (hu) 2003-08-28
ZA200209452B (en) 2004-02-20
CZ20024014A3 (cs) 2003-04-16
KR20030028752A (ko) 2003-04-10
BR0111445A (pt) 2003-06-03
HK1052012A1 (en) 2003-08-29
US20100249083A1 (en) 2010-09-30
PT1294739E (pt) 2005-06-30
ATE293124T1 (de) 2005-04-15
TWI225068B (en) 2004-12-11
JP5095902B2 (ja) 2012-12-12
MXPA02012117A (es) 2003-06-06
US20110224183A1 (en) 2011-09-15
CN1235908C (zh) 2006-01-11
ES2240454T3 (es) 2005-10-16
CA2410220C (en) 2009-04-28
PL359238A1 (en) 2004-08-23
PL203732B1 (pl) 2009-11-30
IL152957A0 (en) 2003-06-24
WO2002000682A1 (en) 2002-01-03
DK1294739T3 (da) 2005-08-01
AR028080A1 (es) 2003-04-23
EP1294739B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
EP1272504B1 (de) 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene
JP3273010B2 (ja) 性ステロイド活性阻害剤
IL94992A (en) History of androstane that prevents sexual steroid activity and pharmacy preparations containing them
EP0367576A2 (en) Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
DE60025958T2 (de) 14,15-beta-methylen substituierte androgene
RU2182153C2 (ru) Стероидное соединение, способы его получения, фармацевтическая композиция
US20110224183A1 (en) 16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity
EP1226155A2 (de) 18-nor-steroide als selektiv wirksame estrogene
AU2001258386A1 (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
DE10019167A1 (de) Substituierte Estratriene als selektiv wirksame Estrogene
SK882003A3 (en) 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
US6949531B2 (en) 14 β, 16, 17-methylene steroids as novel androgens
DE19954105A1 (de) 18-Nor-Steroide als selektiv wirksame Estrogene

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110501